← Back to news
NewsPHARMACEUTICALS (BASEL, SWITZERLAND)Friday, February 27, 2026 · February 27, 2026

Cannabidiol in Neurology: Current Insights and Translational Perspectives.

WHY IT MATTERS

Recent peer-reviewed research on Lennox-Gastaut syndrome that may be relevant for patients and caregivers.

Cannabidiol (CBD) is one of the most studied compounds of Cannabis sativa and has attracted significant interest due to its therapeutic and beneficial properties, which have been confirmed in numerous preclinical and clinical studies over the last few years. A great advantage of CBD over the other w...

Read on PubMed
Read the original at Pharmaceuticals (Basel, Switzerland)
ResearchPubMedLennox-Gastaut syndrome

Related conditions

Lennox-Gastaut syndrome

Related news

Int J Circumpolar Health · -222 days ago
A population-based legacy study of myasthenia gravis in Iceland: insights from a small Arctic nation
Published in Int J Circumpolar Health. Hjaltason H et al.
Health Inf Sci Syst · -192 days ago
PhenoRareAI: Phenotype-based intelligent diagnosis for rare neuromuscular disorders of glycogen storage disease and spinal muscular atrophy
Published in Health Inf Sci Syst. Zhai W et al.
Ther Adv Rare Dis · -192 days ago
Could an outcome-based agreement be operationalized using real-world data from the Canadian Neuromuscular Disease Registry? Perspectives from an expert-led assessment in spinal muscular atrophy
Published in Ther Adv Rare Dis. Mitha A et al.
J Allergy Clin Immunol Glob · -39 days ago
Emerging trends and research hot spots in inborn error of immunity: A bibliometric perspective
Published in J Allergy Clin Immunol Glob. Alblooshi H et al.